UroGen Pharma Ltd (URGN) — Long-term Investment Intensity
UroGen Pharma Ltd (URGN) has a Long-term Investment Intensity of 0.2% as of September 2025. Long-term investments of $380.00K represent 0.2% of total assets of $185.05 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of UroGen Pharma Ltd to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
UroGen Pharma Ltd Long-term Investment Intensity (2019–2024)
This chart shows how UroGen Pharma Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2019 to 2024. As of September 2025, the intensity stands at 0.2%, reflecting long-term investments of $380.00K against total assets of $185.05 Million USD. Explore URGN operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for UroGen Pharma Ltd (2019–2024)
The table below presents the year-by-year Long-term Investment Intensity for UroGen Pharma Ltd from 2019 to 2024, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is UroGen Pharma Ltd worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 1.8% | $5.02 Million | $285.71 Million | ▼ -0.8 pp |
| 2023 | 2.5% | $4.50 Million | $178.31 Million | ▲ +2.0 pp |
| 2021 | 0.6% | $675.00K | $119.75 Million | ▼ -1.0 pp |
| 2020 | 1.6% | $1.89 Million | $122.00 Million | ▼ -22.4 pp |
| 2019 | 24.0% | $48.55 Million | $202.39 Million | — |